Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Sequential treatment of HCC cells with mTOR pathway inhibitors prior to Sorafenib attenuates cancer stem cell enrichment
Date
2016-07-01
Author
Kahraman, Deniz Cansen
ATALAY, RENGÜL
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
12
views
0
downloads
Cite This
URI
https://www.ejcancer.com/issue/S0959-8049(16)X0014-7
https://hdl.handle.net/11511/112807
Conference Name
24th Biennial Congress of the European Association for Cancer Research
Collections
Graduate School of Informatics, Conference / Seminar
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
D. C. Kahraman and R. ATALAY, “Sequential treatment of HCC cells with mTOR pathway inhibitors prior to Sorafenib attenuates cancer stem cell enrichment,” presented at the 24th Biennial Congress of the European Association for Cancer Research, Manchester, İngiltere, 2016, Accessed: 00, 2024. [Online]. Available: https://www.ejcancer.com/issue/S0959-8049(16)X0014-7.
